Tag: Back-to-back gene therapy

Cell and Gene Therapy, Industry

Back-to-back gene therapy approvals give Bluebird shot at survival

September 19, 2022

Via: Biopharma Dive

Until this August, just two gene therapies for inherited diseases were available in the U.S. Now, in the span of one month, that count has doubled, with the Food and Drug Administration approving new treatments for a rare blood condition […]